Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630161 · ClinicalTrials.gov registry record · NA
Smoking Relapse-Prevention Intervention for Cancer Patients
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 441
- Enrollment target
NCT01630161 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 441 participants.
The verdict
NCT01630161, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 441 participants
- Enrollment target
Study Summary
The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Smoking Relapse Prevention for Cancer Patients (SRP-CaP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 441 participants |
| Start Date | 2012-01-04 |
| Est. Completion | 2020-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01630161
The ClinicalTrials.gov registry entry for NCT01630161 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 441 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT01630161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01630161 about?
NCT01630161 is a clinical study titled "Smoking Relapse-Prevention Intervention for Cancer Patients". The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.
What is the current status of trial NCT01630161?
This trial is currently completed. It is a NA study. The enrollment target is 441 participants. The study started on 2012-01-04. Estimated completion is 2020-11-18.
What interventions are being tested in trial NCT01630161?
The interventions under investigation include: Usual Care (BEHAVIORAL), Smoking Relapse Prevention for Cancer Patients (SRP-CaP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01630161?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.